4//SEC Filing
Inman Todd 4
Accession 0001628280-22-026029
CIK 0001448431other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 1:13 PM ET
Size
11.0 KB
Accession
0001628280-22-026029
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Inman Todd
Chief Technology Officer
Transactions
- Award
Stock Option
2022-10-03+19,527→ 19,527 totalExercise: $15.04Exp: 2027-10-02→ Common Stock (19,527 underlying) - Award
Restricted Stock Units
2022-10-03+9,973→ 9,973 total→ Common Stock (9,973 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F2]The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.
- [F3]The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001858241
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 1:13 PM ET
- Size
- 11.0 KB